2021 Fourth Quarter Earnings (Unaudited) January 25, 2022 -- 1 of 15 -- 22 2021 Q4 Earnings – January 25, 2022. All rights reserved. Events Upcoming events Strategic Update and 2022 Outlook meeting February 14 Q1 earnings April 26 -- 2 of 15 -- 33 2021 Q4 Earnings – January 25, 2022. All rights reserved. Forward looking statement This presentation contains forward-looking information about 3M's financial results and estimates and business prospects that involve substantial risks and uncertainties. You can identify these statements by the use of words such as "anticipate," "estimate," "expect," "aim," "project," "intend," "plan," "believe," "will," "should," "could," "target," "forecast" and other words and terms of similar meaning in connection with any discussion of future operating or financial performance or business plans or prospects. Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, regulatory, capital markets and other external conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) risks related to public health crises such as the global pandemic associated with the coronavirus (COVID-19); (3) foreign currency exchange rates and fluctuations in those rates; (4) liabilities related to certain fluorochemicals, including lawsuits concerning various PFAS-related products and chemistries, and claims and governmental regulatory proceedings and inquiries related to PFAS in a variety of jurisdictions; (5) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10-K for the year ended Dec. 31, 2020, and any subsequent quarterly reports on Form 10-Q (the “Reports”); (6) competitive conditions and customer preferences; (7) the timing and market acceptance of new product offerings; (8) the availability and cost of purchased components, compounds, raw materials, labor, and energy (including oil and natural gas and their derivatives) due to shortages, increased demand and wages, logistics, manufacturing site disruption or supply chain interruptions (including those caused by natural and other disasters and other events); (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) the impact of acquisitions, strategic alliances, divestitures and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (11) operational execution, including scenarios where the Company generates fewer productivity improvements than estimated; (12) financial market risks that may affect the Company’s funding obligations under defined benefit pension and postretirement plans; (13) the Company's credit ratings and its cost of capital; and (14) tax-related external conditions, including changes in tax rates, laws or regulations. Changes in such assumptions or factors could produce significantly different results. A further description of these factors is located in the Reports under "Cautionary Note Concerning Factors That May Affect Future Results" and "Risk Factors" in Part I, Items 1 and 1A (Annual Report) and in Part I, Item 2 and Part II, Item 1A (Quarterly Reports), as updated by applicable Current Reports on Form 8-K. The information contained in this presentation is as of the date indicated. The Company assumes no obligation to update any forward-looking statements contained in this presentation as a result of new information or future events or developments. This presentation refers to certain non-GAAP financial measures. Refer to 3M’s January 25, 2022, press release for descriptions of non-GAAP financial measures such as free cash flow, adjusted free cash flow, free cash flow conversion, adjusted free cash flow conversion, net debt, adjusted EBITDA, and various measures that adjust for the impacts of special items. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures can be found in that press release. Note on non-GAAP financial measures -- 3 of 15 -- 44 2021 Q4 Earnings – January 25, 2022. All rights reserved. KEY TAKEAWAYS • Delivered solid Q4 results in the face of continued fluid environment • December better than expected: o Effectively managed significant disruptions in global supply chains and logistics challenges to serve customers; o Strong focus on productivity actions and spending discipline; and o COVID-19 Omicron variant driving an increase in near-term demand for disposable respirators • Selling price momentum gaining traction as previously communicated • Overall end-market demand remains strong and longer term we are well-positioned for driving growth in large, attractive markets including automotive, home improvement, safety, healthcare, and electronics • Portfolio prioritization: announced divestitures of food safety and floor care products business to enhance shareholder value • Capital allocation priorities: growth, productivity and sustainability, while returning significant capital to shareholders • Full-year 2022 guidance to be provided on February 14 at Strategic Update and 2022 Outlook meeting Organic local- currency growth Operating margin Earnings per share +1.3% 18.8% $2.31 Q4 2021 Serving customers while navigating external challenges -- 4 of 15 -- 55 2021 Q4 Earnings – January 25, 2022. All rights reserved. Q4 2021 operating margin and EPS +9.0% Operating margin Earnings per share Q4 2020 21.5% $2.41 Organic volume/ productivity and other -2.4% -$0.33 • Org vol impact -1.3% • Manufacturing headwinds from global supply chain challenges and increased comp/benefits costs more than offsetting strong spending discipline and benefits from restructuring actions • Increased investments in growth, productivity and sustainability • Lower restructuring charges (margin/EPS YoY impact: +140 bps/+$0.18) • Lower gain on sales of properties (margin/EPS YoY impact: -60 bps/-$0.08) • Smaller increase in respirator mask reserve; higher litigation-related costs Price/raw material -0.2% +$0.03 • Selling price actions mitigating raw material and logistics cost inflation FX -0.1% -$0.04 • Net of hedge impact Other expense/income NA +$0.10 • Primarily non-operating pension benefit and lower net interest expense Tax rate* NA +$0.12 • Q4 2021 tax rate 14.5% versus 18.6% in prior year Shares outstanding NA +$0.02 • Average diluted shares down 1% Q4 2021 18.8% $2.31 * The effect of income taxes on items that had specific tax rates are reflected within their respective impacts in the table above. -- 5 of 15 -- 66 2021 Q4 Earnings – January 25, 2022. All rights reserved. Q4 2021 cash flow and balance sheet Proactive balance sheet management • Net debt of $12.6B, down $1.2B, or 8% YoY Adjusted free cash flow • Q4: $1.5B, down 30%; FY: $6.0B, down 11% Adjusted free cash flow conversion • Q4: 110%, down 40 ppts; FY: 101%, down 30 ppts • Q4 YoY decline due to lower non-cash expenses vs. Q4 2020 (legal and restructuring), higher litigation-related payments and capex investments, partially offset by improvements in the working capital cycle Capital expenditures • Q4: $556M, up $134M; FY: $1.6B, up $102M Cash returned to shareholders • Q4: dividends $848M; gross share repurchases $938M • FY: dividends $3.4B; gross share repurchases $2.2B $1.5B -30% year-on-year Adjusted free cash flow 110% -40 ppts year-on-year Adjusted free cash flow conversion $1.8B +110% year-on-year Cash returned to shareholders -- 6 of 15 -- 77 2021 Q4 Earnings – January 25, 2022. All rights reserved. Business Group performance FY 2021 Q4 2021 Organic growth Operating margin Organic growth Operating margin Q4 commentary Safety & Industrial 7.8% 20.9% -1.3% 17.7% • Organic growth led by strength in closure and masking systems, abrasives, industrial adhesives and tapes and electrical markets, more than offset by personal safety declines due to prior-year strong COVID-related respiratory demand (disposable respirator decline reduced segment organic growth by ~4 ppts) • Disposable respirator sales declined 25% organically YoY, and 7% sequentially • Operating margins -4.4 ppts YoY; increased raw materials, logistics and litigation-related costs; manufacturing productivity impacts; and lower gain on sales of properties, partially offset by selling price actions; strong spending discipline; smaller increase in respirator mask reserve; restructuring benefits and lower YoY related charges Transportation & Electronics 9.0% 20.6% -0.4% 17.6% • Organic growth led by commercial solutions and advanced materials; organic sales declined in electronics and auto OEM (due to continued impact of semiconductor constraints) and transportation safety • Operating margins -2.7 ppts YoY; increased raw materials and logistics costs; manufacturing productivity impacts; and increased comp/benefits costs, partially offset by selling price actions; strong spending discipline; restructuring benefits and lower YoY related charges Health Care 8.6% 23.8% 1.6% 23.6% • Organic growth led by separation and purification sciences, food safety, health information systems and oral care, partially offset by medical solutions declines due to lower YoY disposable respirator sales (disposable respirator decline reduced segment organic growth by ~4 ppts) • Operating margins -0.5 ppts YoY; increased raw materials and logistics costs; food safety deal-related costs; manufacturing productivity impacts; and increased comp/benefits costs, partially offset by sales growth (including selling price actions); strong spending discipline; restructuring benefits and lower YoY related charges Consumer 9.3% 21.3% 4.9% 21.4% • Organic growth led by office and stationery, consumer health and safety, and home improvement • Operating margins -1.0 ppt YoY; increased raw materials, logistics and outsourced hardgoods manufacturing costs; manufacturing productivity impacts; and increased comp/benefits costs, partially offset by sales growth (including selling price actions); strong spending discipline; restructuring benefits and lower YoY related charges -- 7 of 15 -- 88 2021 Q4 Earnings – January 25, 2022. All rights reserved. 2021 full-year performance and highlights Organic local-currency growth 8.8% Earnings per share $10.12 Adj. free cash flow conversion 101% • Generated broad-based organic growth across businesses and invested in large and attractive end-markets that align with key global trends • Executed well with good margins, strong earnings per share and free cash flow despite significant raw materials and logistics cost inflation and global supply chain challenges • Accelerating ESG leadership: investing $1 billion over the next 20 years to accelerate air and water stewardship; new plastics reduction goals; and introduced diversity, equity and inclusion report • Prioritizing portfolio management, including announced divestitures of food safety and floor care products business to enhance shareholder value • Focused on transformation including accelerating our digital strategy to better serve customers and improve efficiency of operations and successfully executed our restructuring program that was announced in December 2020 • Generated $6 billion of adjusted free cash flow and strengthened the balance sheet providing financial flexibility while returning $5.6 billion to shareholders -- 8 of 15 -- 99 2021 Q4 Earnings – January 25, 2022. All rights reserved. Q&A Mike Roman Chairman of the Board & Chief Executive Officer Monish Patolawala Executive Vice President, Chief Financial & Transformation Officer Bruce Jermeland Senior Vice President, Investor Relations -- 9 of 15 -- 10 10 2021 Q4 Earnings – January 25, 2022. All rights reserved. Appendix -- 10 of 15 -- 11 11 2021 Q4 Earnings – January 25, 2022. All rights reserved. Q4 2021 P&L ($M) Q4 2020 Q4 2021 Change Sales $8,583 $8,612 +0.3% Gross profit $4,195 $3,914 -6.7% % to sales 48.8% 45.5% -3.3 pts SG&A $1,890 $1,824 -3.4% % to sales 22.0% 21.2% -0.8 pts R&D & related $456 $474 +4.0% % to sales 5.3% 5.5% +0.2 pts Gain on sale of businesses — — — % to sales — — — Operating income $1,849 $1,616 -12.6% % to sales 21.5% 18.8% -2.7 pts Net income $1,405 $1,339 -4.7% GAAP earnings per share $2.41 $2.31 -4.1% -- 11 of 15 -- 12 12 2021 Q4 Earnings – January 25, 2022. All rights reserved. Q4 2021 sales recap Americas EMEA APAC Worldwide Organic volume -1.7% -3.2% +0.2% -1.3% Price +3.9% +1.3% +1.2% +2.6% Organic local-currency +2.2% -1.9% +1.4% +1.3% Acquisitions/divestitures —% —% —% —% FX -0.1% -2.6% -1.6% -1.0% Total growth +2.1% -4.5% -0.2% +0.3% U.S. Canada Mexico Brazil China/HK Japan Organic local-currency +1% +6% +9% +4% +2% -6% -- 12 of 15 -- 13 13 2021 Q4 Earnings – January 25, 2022. All rights reserved. Business segment information ($M) Net Sales Q4 2021 Sales Growth Organic local-currency by Geographic Area Business Segment Operating Income/Adjusted Operating Income* Business Segment Operating Margin/Adjusted Operating Margin* Business groups Q4 2020 Q4 2021 Organic local- currency FX M&A Total Sales Change Americas Asia Pacific EMEA Q4 2020 Q4 2021 Percent change Q4 2020 Q4 2021 Safety & Industrial $3,133 $3,064 -1.3% -0.9% —% -2.2% -3.3% 8.7% -7.4% $693 $543 -21.7% 22.1% 17.7% Transportation & Electronics $2,341 $2,306 -0.4% -1.1% —% -1.5% 6.7% -4.5% 2.0% $476 $406 -14.7% 20.3% 17.6% Health Care $2,258 $2,275 1.6% -0.9% —% 0.7% 0.1% 9.7% -0.9% $544 $536 -1.6% 24.1% 23.6% Consumer $1,418 $1,476 4.9% -0.8% —% 4.1% 6.0% 4.4% -2.1% $317 $316 -0.4% 22.4% 21.4% Elimination of Dual Credit $(566) $(509) $(147) $(125) Total Operating Business Segment $1,883 $1,676 Corporate & Unallocated $(1) $— $(34) $(60) Total $8,583 $8,612 1.3% -1.0% —% 0.3% 2.2% 1.4% -1.9% $1,849 $1,616 -12.6% 21.5% 18.8% * “Corporate and Unallocated” and “Total” provided on an adjusted basis Organic local-currency = organic volume + price -- 13 of 15 -- 14 14 2021 Q4 Earnings – January 25, 2022. All rights reserved. Additional sales detail ($M) Net Sales Business groups Q4 2020 Q4 2021 Abrasives 318 343 Automotive Aftermarket 305 302 Closure and Masking Systems 248 272 Electrical Materials 292 306 Industrial Adhesives & Tapes 683 718 Personal Safety 1,212 1,024 Roofing Granules 95 90 Other Safety & Industrial (20) 9 Total Safety & Industrial Business Group 3,133 3,064 Advanced Materials 266 280 Automotive & Aerospace 488 433 Commercial Solutions 381 417 Electronics 999 974 Transportation Safety 212 191 Other Transportation & Electronics (5) 11 Total Transportation & Electronics Business Group 2,341 2,306 ($M) Net Sales Business groups Q4 2020 Q4 2021 Drug Delivery — — Food Safety 89 94 Health Information Systems 307 323 Medical Solutions 1,316 1,285 Oral Care 335 341 Separation & Purification Sciences 214 227 Other Health Care (3) 5 Total Health Care Business Group 2,258 2,275 Consumer Health & Safety 132 148 Home Care 270 268 Home Improvement 625 638 Stationery & Office 354 387 Other Consumer 37 35 Total Consumer Business Group 1,418 1,476 Corporate & Unallocated (1) — Elimination of Dual Credit (566) (509) Total 8,583 8,612 -- 14 of 15 -- -- 15 of 15 --